FMP
Nyxoah S.A.
NYXH
NASDAQ
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
11.36 USD
-0.11 (-0.968%)
Valuation Date:
Mar 21, 2025 4:00 PM
Share Price on Valuation Date
$11.36
Stock Beta
0.612
Shares Outstanding
34386800